Patents by Inventor Paulino Carlos Gonzalez-Hernandez

Paulino Carlos Gonzalez-Hernandez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Influenza H5 vaccines
    Patent number: 10369211
    Abstract: The present invention is based on the surprising finding that H5 protein of clade 1 H5N1 induces, in particular by a single-shot vaccination, a cross-clade protective immune response to influenza viruses with H5N1 HA. In one aspect, the invention is thus directed to H5 protein of clade 1 H5N1 virus for use in a method of treating or preventing infections with H5N1 virus of a different clade, namely of a clade different from clade 1 or from any clade with the exception of clade 1, respectively.
    Type: Grant
    Filed: July 28, 2017
    Date of Patent: August 6, 2019
    Inventors: Mauricio Realpe-Quintero, Paulino Carlos Gonzalez-Hernandez, Eric Vaughn
  • INFLUENZA H5 VACCINES
    Publication number: 20170348413
    Abstract: The present invention is based on the surprising finding that H5 protein of clade 1 H5N1 induces, in particular by a single-shot vaccination, a cross-clade protective immune response to influenza viruses with H5N1 HA. In one aspect, the invention is thus directed to H5 protein of clade 1 H5N1 virus for use in a method of treating or preventing infections with H5N1 virus of a different clade, namely of a clade different from clade 1 or from any clade with the exception of clade 1, respectively.
    Type: Application
    Filed: July 28, 2017
    Publication date: December 7, 2017
    Inventors: Mauricio REALPE-QUINTERO, Paulino Carlos GONZALEZ-HERNANDEZ, Eric VAUGHN
  • H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
    Patent number: 9375469
    Abstract: The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals.
    Type: Grant
    Filed: October 23, 2013
    Date of Patent: June 28, 2016
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Eric Martin Vaughn, Paulino Carlos Gonzalez-Hernandez, Juergen Daemmgen
  • INFLUENZA H5 VACCINES
    Publication number: 20140199337
    Abstract: The present invention is based on the surprising finding that H5 protein of clade 1 H5N1 induces, in particular by a single-shot vaccination, a cross-clade protective immune response to influenza viruses with H5N1 HA. In one aspect, the invention is thus directed to H5 protein of clade 1 H5N1 virus for use in a method of treating or preventing infections with H5N1 virus of a different clade, namely of a clade different from clade 1 or from any clade with the exception of clade 1, respectively.
    Type: Application
    Filed: August 15, 2012
    Publication date: July 17, 2014
    Applicants: BOEHRINGER INGELHEIM VETMEDICA S.A. DE C.V., BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Mauricio Realpe-Quintero, Paulino Carlos Gonzalez-Hernandez, Eric Vaughn
  • NOVEL H5 PROTEINS, NUCLEIC ACID MOLECULES AND VECTORS ENCODING FOR THOSE, AND THEIR MEDICINAL USE
    Publication number: 20140050755
    Abstract: The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals.
    Type: Application
    Filed: October 23, 2013
    Publication date: February 20, 2014
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Eric Martin VAUGHN, Paulino Carlos GONZALEZ-HERNANDEZ, Juergen DAEMMGEN
  • H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
    Patent number: 8592558
    Abstract: The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals.
    Type: Grant
    Filed: May 21, 2012
    Date of Patent: November 26, 2013
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Eric M. Vaughn, Paulino Carlos Gonzalez-Hernandez, Juergen Daemmgen
  • NOVEL H5 PROTEINS, NUCLEIC ACID MOLECULES AND VECTORS ENCODING FOR THOSE, AND THEIR MEDICINAL USE
    Publication number: 20120231027
    Abstract: The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals.
    Type: Application
    Filed: May 21, 2012
    Publication date: September 13, 2012
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Eric VAUGHN, Paulino Carlos GONZALEZ-HERNANDEZ, Juergen DAEMMGEN
  • H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
    Patent number: 8202967
    Abstract: The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals.
    Type: Grant
    Filed: October 24, 2007
    Date of Patent: June 19, 2012
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Eric Vaughn, Paulino Carlos Gonzalez-Hernandez, Juergen Däemmgen
  • NOVEL H5 PROTEINS, NUCLEIC ACID MOLECULES AND VECTORS ENCODING FOR THOSE, AND THEIR MEDICINAL USE
    Publication number: 20080193471
    Abstract: The present invention relates to novel hemagglutinin H5 proteins, nucleic acids and vectors encoding for those as well as vaccines comprising any of such H5 proteins, nucleic acids or vectors encoding for those H5 proteins. Moreover, the present invention also relates to the medicinal use of any of such compositions in humans and animals.
    Type: Application
    Filed: October 24, 2007
    Publication date: August 14, 2008
    Applicant: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Eric Vaughn, Paulino Carlos Gonzalez-Hernandez, Juergen Daemmgen